GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Multicell Technologies MCET · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in USD, from our data supplier.

FY2014

Revenue

$49,300

FY2014FY2014

Net income

−$380,100

FY2014FY2014

Free cash flow

−$1.1m

FY2014FY2014

Shareholders' equity

−$144,300

FY2014FY2014

Income statement

Fiscal years

FY2014
Revenue$49,300
Research and development$323,500
Operating income−$722,800
Net income−$380,100
Diluted earnings per share-0.00

Balance sheet

At each fiscal year end

FY2014
Total assets$126,200
Cash and short-term investments$112,500
Total liabilities$270,500
Debt$86,400
Shareholders' equity−$144,300
Shares outstanding3,726m

Cash flow

Fiscal years

FY2014
Cash from operations−$1.1m
Free cash flow−$1.1m

Latest quarters

By quarter end

Aug 2015May 2015Feb 2015Nov 2014Aug 2014May 2014Feb 2014Nov 2013
Revenue$194,800$585,800$12,300$12,300$12,300$10,000$10,000$10,000
Gross profit$46,200———————
Operating income−$177,000$228,000−$288,900−$242,100$198,700−$370,000−$310,000−$390,000
Net income−$159,300$171,300−$262,300−$3,300$225,000−$320,000−$280,000−$330,000
Diluted earnings per share——-0.00—————
Total assets$296,000$420,700$66,100$126,200$143,900$180,000$270,000$180,000
Cash and short-term investments$281,100$360,000$53,800$112,500$131,400$170,000$240,000$150,000
Debt$85,300$85,300$85,700$86,400$87,700$90,000$90,000$100,000
Shareholders' equity−$267,400−$110,300−$326,600−$144,300−$283,400−$230,000−$370,000−$360,000

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.0%-22.3%-23.9%
Operating income-32.1%-2.4%-9.6%
Net income-40.5%-15.9%-19.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-2120.5%-3031.2%-1703.8%-944.6%
Net margin-1637.6%-2369.0%-1462.0%-1114.8%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%-90%0%0%9233%15900%100%1677721500%169869226%12700%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 20 May 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.